Middletown, DE -- (SBWIRE) -- 09/07/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: OmniVision Technologies, Inc. (NASDAQ:OVTI), AutoNavi Holdings Ltd (ADR) (NASDAQ:AMAP), Zogenix, Inc. (NASDAQ:ZGNX), Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI).
OmniVision Technologies, Inc.(NASDAQ:OVTI) ended lower -1.09% and complete the day at $15.37. The total number of shares changed hands during the day was 1.07 million. After opening at $15.60, the stock hit as high as $15.66. However, it traded between $12.06 and $20.48 over the last twelve months.
OmniVision Technologies, Inc. engages in designing, developing, and marketing semiconductor image-sensor devices worldwide. It offers CameraChip image sensors, which are single-chip solutions that integrate various functions, such as image capture, image processing, color processing, signal conversion,
Has OVTI Found The Bottom and Ready To Move Up? Find Out Here
AutoNavi Holdings Ltd (ADR)(NASDAQ:AMAP) closed yesterday at $13.05, a +0.77% increase. Around 1.06 million shares were traded, beating an-average trading volume of 823,117 shares. The company is now valued at around $605.42 million.
AutoNavi Holdings Limited, through its subsidiaries, provides digital map content, and navigation and location-based solutions in China. It offers automotive navigation solutions, including digital map data for in-dash navigation systems
For How Long AMAP Gloss will Attract Investors? Find out via this report
Zogenix, Inc.(NASDAQ:ZGNX) moved +1.07 percent higher at $1.89 and traded between $1.75 and $1.95 after opening the day at $1.89. Its performance over the last five days remained 21.15%, which stands at 19.62% for a month. Going back further than one month, 1-year performance after recent close was 42.11%.
Zogenix, Inc., a pharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system disorders and pain. Its commercial product includes Sumavel DosePro (sumatriptan injection), a delivery system that offers needle-free subcutaneous administration of sumatriptan for the acute treatment of migraine and cluster headache.
For How Long ZGNX Gloss will Attract Investors? Find out via this report
Spectrum Pharmaceuticals, Inc.(NASDAQ:SPPI) shares fall, losing -2.47 percent to close at $7.90. The stock is down around -29.38% this year and -33.95% for the last 12 months. Around 1.03 million shares changed hands yesterday, lower from an-average trading volume of 1.08 million shares.
Spectrum Pharmaceuticals, Inc., a biotechnology company, engages in acquiring, developing, and commercializing prescription drug products primarily in the areas of hematology and oncology.
Will SPPI Get Buyers Even After The Recent Rally? Find Out Here
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)